Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China flag China · Delayed Price · Currency is CNY
34.41
-0.25 (-0.72%)
Oct 29, 2026, 4:00 PM EDT

Bright Eye Hospital Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,0122,7672,6602,7051,7151,703
Other Revenue
30.1830.1818.5912.7911.097.4
3,0432,7972,6782,7181,7261,710
Revenue Growth
10.96%4.44%-1.46%57.50%0.91%25.54%
Cost of Revenue
1,7521,6591,5611,424927.51903.36
Gross Profit
1,2901,1391,1171,294798.13806.66
Selling, General & Admin
1,004985.181,012913.35694.23627.16
Research & Development
10.5510.828.0211.036.64-
Other Operating Expenses
3.245.338.125.893.192.67
Operating Expenses
1,0171,0031,028933.65705.65629.83
Operating Income
273.63136.0188.92360.3792.47176.83
Interest Expense
--19.33-16.97-74.67-57.56-48.44
Interest & Investment Income
49.434.28.5495.3529.5413.75
Currency Exchange Gain (Loss)
-0.01-0.01-0.05-0.41-0.01-
Other Non Operating Income (Expenses)
-125.84-73.71-77.67-31.69-13.59-5.87
EBT Excluding Unusual Items
197.2147.162.78348.9650.84136.27
Impairment of Goodwill
-7.69-7.69-4.54--1.64-8.12
Gain (Loss) on Sale of Investments
-8.35-10.17-3.510.1--
Gain (Loss) on Sale of Assets
-0.450-0.930.060.560.93
Asset Writedown
-1.62-1.1-1.46-0.47-0.47-0.5
Other Unusual Items
-23.95-15.69-18.3613.589.9410.33
Pretax Income
155.1512.52-26.02362.2359.23138.9
Income Tax Expense
71.6366.2366.8184.2338.6645.01
Earnings From Continuing Operations
83.53-53.72-92.83278.0120.5793.89
Minority Interest in Earnings
-9.74-7.2-9.03-10.09--
Net Income
73.79-60.92-101.86267.9120.5793.89
Net Income to Common
73.79-60.92-101.86267.9120.5793.89
Net Income Growth
---1202.56%-78.09%-13.81%
Shares Outstanding (Basic)
150149150150129112
Shares Outstanding (Diluted)
150149150150129112
Shares Change
-1.14%-0.80%0.08%16.43%15.01%-0.39%
EPS (Basic)
0.49-0.41-0.681.790.160.84
EPS (Diluted)
0.49-0.41-0.681.790.160.84
EPS Growth
---1018.75%-80.95%-13.40%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
402.68318.45-160.43-12.41-8.68104.62
Free Cash Flow Per Share
2.682.14-1.07-0.08-0.070.94
Dividend Per Share
---0.4000.100-
Dividend Growth
---300.00%--
Gross Margin
42.41%40.71%41.70%47.61%46.25%47.17%
Operating Margin
8.99%4.86%3.32%13.26%5.36%10.34%
Profit Margin
2.43%-2.18%-3.80%9.86%1.19%5.49%
Free Cash Flow Margin
13.23%11.38%-5.99%-0.46%-0.50%6.12%
EBITDA
430.36278.86213.26451.57162.32232.68
EBITDA Margin
14.14%9.97%7.96%16.61%9.41%13.61%
D&A For EBITDA
156.73142.85124.3491.269.8455.85
EBIT
273.63136.0188.92360.3792.47176.83
EBIT Margin
8.99%4.86%3.32%13.26%5.36%10.34%
Effective Tax Rate
46.16%529.21%-23.25%65.27%32.41%
Revenue as Reported
596.712,7972,6782,7181,7261,710
Advertising Expenses
-230.39220.74240.06197.96178.68